Abstract:Although combination antiretroviral therapy (ART) has been a landmark achievement for the treatment of human immunodeficiency virus (HIV), an HIV cure has remained elusive. Elimination of latent HIV reservoirs that persist throughout HIV infection is the most challenging barrier to an HIV cure. The progressive HIV infection is marked by the increasing size and diversity of latent HIV reservoirs until an effective immune response is mobilized, which can control but not eliminate HIV infection. The stalemate between HIV replication and the immune response is manifested by the establishment of a viral set point. ART initiation during the early stage limits HIV reservoir development, preserves immune function, improves the quality of life, and may lead to ART-free viral remission in a few people living with HIV (PLWH). However, for the overwhelming majority of PLWH, early ART initiation alone does not cure HIV, and lifelong ART is needed to sustain viral suppression. A critical area of research is focused on determining whether HIV could be functionally cured if additional treatments are provided alongside early ART. Several HIV interventions including Block and Lock, Shock and Kill, broadly neutralizing antibody (bNAb) therapy, adoptive CD8+ T cell therapy, and gene therapy have demonstrated delayed viral rebound and/or viral remission in animal models and/or some PLWH. Whether or not their application during early infection can improve the success of HIV remission is less studied. Herein, we review the current state of clinical and investigative HIV interventions and discuss their potential to improve the likelihood of post-treatment remission if initiated during early infection.

HIV Pol: does it offer therapeutic targets for HIV?

Recent progress on functional cure for acquired immunodeficiency syndrome

Translational eradication approaches

Interventions during Early Infection: Opening a Window for an HIV Cure?

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

Advanced Therapies for Human Immunodeficiency Virus

Gene therapy for HIV infection

Strategies for HIV-1 suppression through key genes and cell therapy

Targeting Viral Transcription for HIV Cure Strategies

Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure

Targeting HIV persistence in the tissue

Strategies for Inhibiting Function of HIV-1 Accessory Proteins: A Necessary Route to AIDS Therapy?

Utilizing immunotherapy towards achieving a functional cure for HIV-1

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection

Integrase inhibitors: current protagonists in antiretroviral therapy

HIV/AIDS Curable Study: New Forms of Therapeutic Trinity

Opportunities and challenges in new HIV therapeutic discovery: what is the next step?

Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure

Cell membrane anchoring strategies for HIV gene therapy

Treatment of Human Immunodeficiency Virus-1: Current Challenges and Future Perspectives

HIV-1 functional cure: will the dream come true?